Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2019-10-01
2020-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Qualitative methodology and specifically the long interview is the method the team will use to gain insight into adult patients' perceptions of their food story.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
NCT05178498
Rx for Better Breast Health
NCT02279303
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women
NCT00900367
Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging
NCT01277263
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
NCT00530751
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Clinical faculty will receive an oral and written overview of the project prior to beginning in case they have patients they want to recommend to participate.
3. Physician will approach individual patients to participate during a regular medical office visit, patients will be given an introduction and overview of the study, and then will be asked if they would like to participate in the study.
4. If the patient wants to participate, Malika Siker, MD will schedule a time for the patient to meet with a member of the study team to conduct the interview.
5. The interview will be scheduled at a time convenient for the patient.
6. If the patient does not want to participate, no further action is required
7. All study subjects will be adults with the ability to understand the study and consent to participate.
8. The sample will be a convenience sample based upon interest in participating.
9. At the time of the interview, patients will receive a written and oral overview of the research.
10. The subject will have ample time to ask questions before completing the survey or beginning the interview.
All study subjects will understand and agree to having the interview audiotaped.
11. The interview will take place immediately after the subject has agreed to participate.
12. Interviews will last between approximately 60 minutes. Subjects can decline to answer any question and can withdraw from the study at any time during the process.
13. Our highest estimate is that 50 subjects will be needed to complete the project.
14. Interviews will be audiotaped and transcribed verbatim by a transcription service following the conclusion of the interview.
15. The transcriptionist will be instructed to remove any names of individuals that may be discussed by the subject.
16. Transcriptions will be placed in a password protected computer file.
17. PI will review the transcripts to ensure that transcriptions are anonymous.
18. When determined, PI will instruct that the recording be erased.
19. The team will only begin analysis after ensuring that all transcripts are anonymous.
20. The team will analyze the data for thick description and for themes that emerge during the analysis by following procedures developed by Corbin and Strauss.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
There is no intervention. We are just asking breast cancer patients what their food story is.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
99 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical College of Wisconsin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amy Rymaszewski
Research Associate II
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO00034502
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.